Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases

Journal of Rheumatology

Volumn 25, Issue 4, 1998, Pages 703-709

  Uesugi, Hiroko ^a   Ozaki, Shoichi ^a   Sobajima, Junko ^a   Osakada, Fumio ^b   Shirakawa, Hitoshi ^c   Yoshida, Michiteru ^c   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANEKA CORPORATION   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Anti HMG1 HMG2 antibodies; pANCA; Systemic rheumatic diseases

Indexed keywords

CHROMOSOME PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; GRIP STRENGTH; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; RHEUMATIC DISEASE; TARGET CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; BLOTTING, WESTERN; CATHEPSINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH MOBILITY GROUP PROTEINS; HUMANS; LACTOFERRIN; MALE; MIDDLE AGED; PEROXIDASE; RHEUMATIC DISEASES; SERINE ENDOPEPTIDASES;

EID: 0031898556     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hauschild S, Schmitt WH, Csernok E, Flesch BK, Rautmann A, Gross WL. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. In: Gross WL, editor. ANCA-associated vasculitides: immunological and clinical aspects. New York: Plenum Press, 1993:245-51.
2. Coremans IEM, Hagen EC, Daha MR, et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466-75.
3. Lesavre P, Nöel LH, Gayno S, et al. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies: specificity and clinical associations. J Autoimmun 1993;6:185-95.
4. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CG. Antineutropohil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlations. Arthritis Rheum 1993;36:1054-60.
5. Bosch X, Llena J, Collado A, et al. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis. J Rheumatol 1995;22:2038-45.
6. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
7. Braun AR, Csernok E, Schmitt WL, Gross WL. Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 1996;23:826-30.
8. Sobajima J, Ozaki S, Okazaki T, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 1996;105:120-4.
9. Sobajima J, Ozaki S, Osakada F, et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol 1997;107:135-40.
10. Aizawa S, Nishino H, Saito K, Kimura K, Shirakawa H, Yoshida M. Stimulation of transcription in cultured cells by high mobility group protein 1: essential role of the acidic carboxyl-terminal region. Biochemistry 1994;33:14690-5.
11. Ogawa Y, Aizawa S, Shirakawa H, Yoshida M. Stimulation of transcription accompanying relaxation of chromatin structure in cells overexpressing high mobility group 1 protein. J Biol Chem 1995;270:9272-80.
12. Craft J, Hardin JA. Antinuclear antibodies. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology, 4th ed. Philadelphia: WB Saunders, 1993:164-87.
13. Einck L, Bustin M. The intracellular distribution and function of the high mobility group chromosomal proteins. Exp Cell Res 1985;156:295-310.
14. Bustin M, Neihart NK. Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell 1979;16:181-9.
15. Bustin M, Reish J, Einck L. Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases. Science 1982;215:1245-7.
16. Wittemann B, Neuer G, Michels H, Truckenbrodt H, Bautz FA. Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum 1990;33:1378-83.
17. Ayer LM, Sénecal J-L, Martin L, Dixon GH, Fritzler MJ. Antibodies to high mobility group proteins in systemic sclerosis. J Rheumatol 1994;21:2071-5.
18. Morse JH, Barst RJ, Fotimo M, Zhang Y, Flaster E, Fritzler MJ. Primary pulmonary hypertension: immunogenetic response to high-mobility group proteins and histone. Clin Exp Immunol 1996;106:389-95.
19. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1990;1049:231-43.
20. Shirakawa H, Yoshida M. Structure of a gene coding for human HMG2 protein. J Biol Chem 1992;267:6641-5.
21. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
23. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
24. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
25. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7;403-7.
26. Mizushima Y. Recent research into Behçet's disease in Japan. Int J Tissue React 1988;10:59-65.
27. Lightfoot RW, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
28. Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985;56:467-83.
29. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl 1989;6:12-3.
30. Charles LA, Falk RJ, Jennette JC. Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol 1989;53:243-53.
31. Falk RJ, Jennette JC. Introduction: Third International Workshop on Antineutrophil Cytoplasmic Autoantibodies. Am J Kidney Dis 1991;18:145-7.
32. Adachi Y, Mizuno S, Yoshida M. Efficient large-scale purification of non-histone chromosomal proteins HMG1 and HMG2 by using polybuffer-exchanger PBE94. J Chromatogr 1990;530:39-46.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
34. Lansbury J. Quantitation of activity of rheumatoid arthritis: method for summation of systemic indices of rheumatoid activity. Am J Med Sci 1956;232:300.
35. Schmitt WH, Csernok E, Flesch BH, Gross WL. Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA). In: Gross WL, editor. ANCA-associated vasculitides: immunological and clinical aspects. New York: Plenum Press, 1993:267-72.
36. Yamazaki F, Nagatsuka Y, Shirakawa H, Yoshida M. Repression of cell cycle progression by antisense HMG2 RNA. Biochem Biophys Res Commun 1995;210:1045-51.
37. Merenmies J, Pihlaskari R, Laitinen J, Wartiovaara J, Rauvala H. 30-kDa heparin-binding protein of brain (amphoterin) involved in neunte outgrowth: amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991:266:16722-9.
38. Parkkinen J, Raulo E, Merenmies J, et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides: enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 1993;268:19726-38.